![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RM Laethem and DR Koop
Department of Pharmacology, Oregon Health Sciences University, Portland 97201.
Microsomes prepared from COS-1 cells transiently expressing rabbit cytochromes P450 2C1 and 2C2 catalyzed the metabolism of arachidonic acid to predominantly 11,12- and 14,15-epoxyeicosatrienoic acids (EETs) when microsomal epoxide hydrolase activity was inhibited by 0.2 mM 1,2- epoxy-3,3,3-trichloropropane. P450 2C2 catalyzed the formation of 11,12- EET and 14,15-EET at a ratio of 3.0 and also produced 19- hydroxyeicosatetraenoic acid (19-HETE). The 11,12-EET, 14,15-EET, and 19-HETE represented 48.3, 15.9, and 12.8%, respectively, of the total metabolites formed. P450 2C1 produced a similar but distinct ratio of 11,12-EET to 14,15-EET (2.0) and did not produce any detectable 19- HETE. The 11,12-EET and 14,15-EET represented 63.0 and 31.1%, respectively, of the total metabolites formed. The 8,9- and 5,6-EETs were not detected with either enzyme. The ratio of the 11,12-EET to 14,15-EET was 1.5 with P450 2CAA, a P450 arachidonic acid epoxygenase (P450 2CAA) that had an amino-terminal sequence identical to that of P450 2C2 [J. Biol. Chem. 267:5552-5559 (1992)]. P450 2C1, 2C2, and 2CAA metabolized lauric acid. The ratio of omega-1- to omega-hydroxylated laurate was 3.6, 3.4, and 2.4 for P450 2CAA, P450 2C2, and P450 2C1, respectively. Purified P450 2CAA had a slightly greater apparent molecular weight than expressed P450 2C2 on sodium dodecyl sulfate- polyacrylamide gels. The results clearly establish that rabbit P450 2C1 and 2C2 are arachidonic acid epoxygenases, and they suggest that P450 2CAA and 2C2 are very similar but may not be identical isoforms.
This article has been cited by other articles:
|
|
 |
|
  R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Lasker, W. B. Chen, I. Wolf, B. P. Bloswick, P. D. Wilson, and P. K. Powell Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney. ROLE OF CYP4F2 AND CYP4A11 J. Biol. Chem., February 11, 2000; 275(6): 4118 - 4126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Mastyugin, E. Aversa, A. Bonazzi, C. Vafaes, P. Mieyal, and M. L. Schwartzman Hypoxia-Induced Production of 12-Hydroxyeicosanoids in the Corneal Epithelium: Involvement of a Cytochrome P-4504B1 Isoform J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1611 - 1619. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau Peroxisome Proliferator-activated Receptor alpha Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes J. Biol. Chem., November 20, 1998; 273(47): 31581 - 31589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Adas, F. Berthou, D. Picart, P. Lozac'h, F. Beaugé, and Y. Amet Involvement of cytochrome P450 2E1 in the ({omega}–1)-hydroxylation of oleic acid in human and rat liver microsomes J. Lipid Res., June 1, 1998; 39(6): 1210 - 1219. [Abstract] [Full Text]
|
|
|
|
|
|
P. K. Powell, I. Wolf, R. Jin, and J. M. Lasker Metabolism of Arachidonic Acid to 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid by P450 Enzymes in Human Liver: Involvement of CYP4F2 and CYP4A11 J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1327 - 1336. [Abstract] [Full Text]
|
|
|
|
|
|
D. S. Keeney, C. Skinner, S. Wei, T. Friedberg, and M. R. Waterman A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid J. Biol. Chem., April 10, 1998; 273(15): 9279 - 9284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Wang, E. Brand-Schieber, B. A. Zand, X. Nguyen, J. R. Falck, N. Balu, and M. L. Schwartzman Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 966 - 973. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. L. Kroetz, L. M. Huse, A. Thuresson, and M. P. Grillo Developmentally Regulated Expression of the CYP4A Genes in the Spontaneously Hypertensive Rat Kidney Mol. Pharmacol., September 1, 1997; 52(3): 362 - 372. [Abstract] [Full Text]
|
|
|
|
|
|
M. B. Sewer, D. R. Koop, and E. T. Morgan Differential Inductive and Suppressive Effects of Endotoxin and Particulate Irritants on Hepatic and Renal Cytochrome P-450 Expression J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1445 - 1454. [Abstract] [Full Text]
|
|
|
|
|
|
C.-D. Chen and B. Kemper Different Structural Requirements at Specific Proline Residue Positions in the Conserved Proline-rich Region of Cytochrome P450 2C2 J. Biol. Chem., November 8, 1996; 271(45): 28607 - 28611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Jacobs and J. G. Douglas Angiotensin II Type 2 Receptor Subtype Mediates Phospholipase A2–Dependent Signaling in Rabbit Proximal Tubular Epithelial Cells Hypertension, October 1, 1996; 28(4): 663 - 668. [Abstract] [Full Text]
|
|
|
|
|
|
S. Wu, C. R. Moomaw, K. B. Tomer, J. R. Falck, and D. C. Zeldin Molecular Cloning and Expression of CYP2J2, a Human Cytochrome P450 Arachidonic Acid Epoxygenase Highly Expressed in Heart J. Biol. Chem., February 16, 1996; 271(7): 3460 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ramarao, P. Straub, and B. Kemper Identification by in Vitro Mutagenesis of the Interaction of Two Segments of C2MstC1, a Chimera of Cytochromes P450 2C2 and P450 2C1 J. Biol. Chem., January 27, 1995; 270(4): 1873 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Salvail, M. Cloutier, and E. Rousseau Functional reconstitution of an eicosanoid-modulated Cl- channel from bovine tracheal smooth muscle Am J Physiol Cell Physiol, March 1, 2002; 282(3): C567 - C577. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
